Cutting Edge: Natalizumab Blocks Adhesion but Not Initial Contact of Human T Cells to the Blood-Brain Barrier In Vivo in an Animal Model of Multiple Sclerosis1
J Immunol (2009) 182 (10): 5909–5913.
Currently there are no citedby results. Try again later.
